New Zealand markets closed

Viveve Medical, Inc. (VIVE)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 10:52AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.14k
Enterprise value -23.86k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.00
Enterprise value/revenue -0.00
Enterprise value/EBITDA 0.00

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 3-99.58%
S&P500 52-week change 322.38%
52-week high 30.1107
52-week low 30.0001
50-day moving average 30.0002
200-day moving average 30.0012

Share statistics

Avg vol (3-month) 32.86k
Avg vol (10-day) 31.31k
Shares outstanding 510.72M
Implied shares outstanding 610.72M
Float 810.72M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (30 Dec 2022) 4374.24k
Short ratio (30 Dec 2022) 44.15
Short % of float (30 Dec 2022) 43.49%
Short % of shares outstanding (30 Dec 2022) 43.49%
Shares short (prior month 30 Nov 2022) 4178.07k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 302 Dec 2020
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 302 Dec 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-276.84%

Management effectiveness

Return on assets (ttm)-62.13%
Return on equity (ttm)-210.99%

Income statement

Revenue (ttm)6.83M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)4.20%
Gross profit (ttm)N/A
EBITDA -20.34M
Net income avi to common (ttm)-28.14M
Diluted EPS (ttm)-2.6500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.91M
Total cash per share (mrq)0.55
Total debt (mrq)6.01M
Total debt/equity (mrq)507.94%
Current ratio (mrq)0.89
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-16.23M
Levered free cash flow (ttm)-7.58M